Global Hospital-Acquired Infection Diagnostics Market Size, Share & Industry Trends Analysis Report By Product (Reagents & Consumables and Instrument), By Infection Type, By Application, By Test Type, By End User, By Regional Outlook and Forecast, 2022 - 2028

The Global Hospital-Acquired Infection Diagnostics Market size is expected to reach $5.6 billion by 2028, rising at a market growth of 7.8% CAGR during the forecast period.

Infections acquired in hospitals are associated with viral, bacterial, or fungal pathogens. Numerous infections can be obtained in clinical settings such as nursing homes, rehabilitation center, outpatient clinics, or other therapeutic settings. It can be acquired from an infected patient, the surrounding environment, or the facility's staff. All patients are at risk for infections acquired in the hospital.

People that had surgery, the children and the elderly, are more likely to get hospital-acquired infections. The most common infections are surgical-site infections, respiratory infections, urinary tract infections, gastrointestinal infections, cardiovascular system infections, bloodstream infections, and bone and joint infections. Hospital-acquired infections (HAIs) are a leading cause of death among hospitalized patients in both developed and emerging countries.

All across the world, the amount of surgical procedures conducted each year has been steadily increasing, and by the end of the decade, it is predicted to hit a new high. As the need for surgical instruments grows along with the number of surgical procedures performed, the risk of healthcare-associated infections is expected to rise. A growing understanding of the value of sterilized and disinfected medical tools and devices would help drive demand for nosocomial infection control equipment. Other factors driving sales of hospital obtained infection control systems include the increased frequency of chronic diseases and advances in surgical equipment.

Many clinicians can identify a HAI (Hospital acquired infection) based just on appearance and symptoms. Inflammation and/or a rash at the infection site might also be signs. HAIs do not include infections that develop complex prior to the stay. However, any additional symptoms should be reported to the doctor during the stay. The treatment for various illnesses is determined by the type of infection. Antibiotics and bed rest are likely to be prescribed by the doctor. It will also remove any foreign devices like catheters as soon as it's medically necessary.

COVID-19 Impact Analysis

COVID-19 was labeled a pandemic and overall well-being crisis of international concern by the World Health Organization (WHO) on January 30, 2020. Around 210 countries have been affected by COVID-19. Governments around the world have imposed mandatory lockdowns and social distancing to prevent the healthcare system from collapsing. Projects and elective procedures have also been subjected to limits and restrictions by states. The roadblocks continue to impede the expansion of various industries, and the increased response to the rules has an impact on the industries. Lockdowns around the world have damaged the distribution, production, and retail networks.

Market Growth Factors

Increasing awareness among people and healthcare institutions

Except for bacterial spores from inanimate things, disinfection is a technique that destroys the majority or all pathogenic microorganisms. Wet pasteurization or liquid chemicals are used to accomplish it. Several factors have influenced disinfection efficiency, each of which might limit the process' efficacy. The use of disinfectants in healthcare facilities to protect people doing the medical process that exposes people to the virus is on the rise. During the COVID-19 pandemic, the need for surface disinfectants was huge and would grow significantly in the coming years.

The growing number of the surgical procedure

The amount of surgical treatment has increased dramatically throughout the years. Every year, many main surgical procedures, are conducted all over the world. The increased incidence of obesity and other lifestyle disorders, the growing senior population, and the rising prevalence of spinal injuries and sports-related injuries are all contributing to the rising cases of surgical procedures. As the amount of surgical treatment performed grows, so does the demand for various surgical equipment and medical gadgets.

Marketing Restraining Factor:

Problems associated with the safety of reprocessed medical instruments

To save money and avoid waste, healthcare practitioners reprocess reusable medical devices. Surgical forceps, stethoscopes, and endoscopes are instances of reusable medical devices. Although, it has questions regarding the reprocessed devices' safety and functionality. Improper instrument cleaning and sterilization can lead to the retention of blood, tissue, and other biological waste in reusable devices, raising the risk of surgical-site infections (SSIs) in patients. Microbes may be able to resist disinfection or sterilization because of the debris, which could contribute to HAIs.

Product Outlook

Based on Product, the market is segmented into Reagents & Consumables and Instrument. The reagents and consumables segment acquired the highest revenue share in the hospital-acquired infection diagnostics market in 2021. This is due to low awareness and a higher incidence of hospital-caused infections in low and medium-income nations. Chemicals and biological agents are employed in laboratory testing to detect or quantify an analyte, or the substance being evaluated or assessed. Cost, stability, availability, cold- or cool-chain requirements, and the risks associated with each variety vary greatly. Consumables are objects that are only utilized once during a test and then discarded and consist of items like coverslips and microscope slides that are specific to the test. Other consumables, which include alcohol, bleach, and gloves, are used throughout all testing services and are categorized as generic laboratory consumables.

Infection Type Outlook

Based on Infection Type, the market is segmented into Urinary Tract Infections (UTI), Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, and Others. The hospital-acquired pneumonia segment garnered a significant revenue share in the hospital-acquired infection diagnostics market in 2021. Hospital-acquired pneumonia (HAP), also known as nosocomial pneumonia, is a lower respiratory infection that was not incubated when the patient was admitted to the hospital and manifests clinically 2 or more days later. Early-onset pneumonia should be considered community-acquired pneumonia.

Application Outlook

Based on Application, the market is segmented into Drug-Resistance Testing and Disease Testing. The drug-resistance testing segment garnered the highest revenue share in the hospital-acquired infection diagnostics market in 2021. This is because drug-resistance testing can be used to see if a drug-resistant virus was spread. When resistance test results are available, the initial regimen can be tweaked if necessary. It is due to the quick turnaround time, reduced cost, and greater sensitivity for detecting mixes of wild-type and resistant virus, genotypic testing is recommended over phenotypic testing.

Test Type Outlook

Based on Test Type, the market is segmented into Molecular Diagnostics, Immunoassay, and Urinalysis. The Immunoassay segment procured a significant revenue share in the hospital-acquired infection diagnostics market in 2021. This test type is in demand due to an increase in infectious diseases, cancer, and pandemic outbreaks. Immunoassay is a highly selective bio-analytical approach that uses an antibody or antigen as a bio-recognition agent to quantify the existence or concentration of analytes ranging from tiny molecules to macromolecules in a solution.

End User Outlook

Based on End User, the market is segmented into Hospital, Standalone Laboratories, and Others. The hospital segment garnered the highest revenue share in the hospital-acquired infection diagnostics market in 2021. It is owing to the outbreak of a pandemic and a massive influx of patients. With the growth of new types of disease and the frequency of contraction of hospital-acquired infection, the role of hospitals comes into greater significance and will always grow in a progressive manner.

Hospital-Acquired Infection Diagnostics Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 3.3 Billion
Market size forecast in 2028	USD 5.6 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 7.8% from 2022 to 2028
Number of Pages	342
Number of Tables	543
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Product, Infection Type, Application, Test Type, End User, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Increasing awareness among people and healthcare institutions The growing number of the surgical procedure
Restraints	Problems associated with the safety of reprocessed medical instruments

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America emerged as the leading region in the hospital-acquired infection diagnostics market with the largest revenue share in 2021. It is due to a rise in the older population and the use of modern diagnostic equipment. As an outcome of the growing emphasis on healthy lifestyles and disease prevention among consumers, the market in this region is characterized by increasing demand for and adoption of sterilization and disinfection goods and services. The rise in the elderly population in the future years, as well as the requirement for hospitals, contracted infection control to reduce the prevalence of HAIs, and the execution of favorable government initiatives and stringent sterilization & disinfection regulations, are all driving the hospital-acquired infection diagnostics market in the region.

Free Valuable Insights: Global Hospital-Acquired Infection Diagnostics Market size to reach USD 5.6 Billion by 2028

KBV Cardinal Matrix - Hospital-Acquired Infection Diagnostics Market Competition Analysis

The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; Johnson & Johnson and Pfizer, Inc. are the forerunners in the Hospital-Acquired Infection Diagnostics Market. Companies such as Abbott, Becton, Dickinson and Company, Ecolab, Inc.  are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG (Bayer Schering Pharma AG), Danaher Corporation, Becton, Dickinson and Company, Hologic, Inc., Ecolab, Inc., Pfizer, Inc., Steris PLC, Johnson & Johnson, Abbott Laboratories, and Merck Group.

Recent Strategies Deployed in Hospital-Acquired Infection Diagnostics Market

» Partnerships, Collaborations and Agreements:

• Apr-2020: Bayer joined hands with OrigiMed, a leading precision medicine company. This collaboration aimed to emphasize developing a CDx-IVD for larotrectinib (Vitrakvi) for the Chinese market and commercialization and development for NGS-based companion diagnostics-in Vitro diagnostic (CDx-IVD) in the detection of NTRK gene fusions.
• Feb-2020: Becton, Dickinson, and Company came into a partnership with Babson Diagnostics, a transformative diagnostic blood testing company. This partnership aimed to bring laboratory-quality, small-volume blood collection to retail pharmacies. The partnership would show emerging health care patterns onto faster, less expensive laboratory testing in customer-friendly healthcare settings with more suitable locations and hours, along with rapid growth in the diagnostic testing market.

» Product Launches and Product Expansions:

• Dec-2021: Hologic unveiled Panther Trax, a new high volume molecular testing platform. This product launch aimed to allow labs to enhance testing volumes without any additional staff. Panther Trax is the new inclusion to Hologic's Panther Scalable Solutions (PSS) portfolio of products for lab automation. The new platform is listed as a Class I medical device with the US Food and Drug Administration (FDA) and CE-marked for diagnostic usage in Europe.
• Dec-2021: Becton, Dickinson, and Company expanded its product line of BD COR System. This product expansion aimed to comprise a new MX instrument for high-throughput infectious diseases testing. This new MX instrument and its test for sexually transmitted infections have been granted CE mark approval, as per the IVD directive 98/79/EC.
• Oct-2021: Hologic unveiled the Novodiag system, a fully automated molecular diagnostic solution for on-demand testing of antimicrobial resistance and infectious diseases. This product launch aimed to allow many pathogens to be identified in a single sample, delivering a simple and quick way to pinpoint patients at higher risk with syndromic and targeted on-demand testing.
• Jul-2021: Abbott introduced Panbio COVID-19 Antigen Self-Test, for detection of SARS-CoV-2 virus in children and adults with symptoms or without any symptoms. This product launch aimed to fasten up testing of symptomatic and asymptomatic individuals and contacts of confirmed coronavirus cases. Abbott would provide numerous Panbio COVID-19 Rapid Antigen Tests accessible for self-use.
• Apr-2020: Hologic released a new Aptima molecular assay. Aptima molecular assay would run on the Panther system, the detection of SARS-CoV-2 virus, which leads to Covid-19. This product launch aimed to level up the testing capabilities in the US by integrating its manufacturing capacity for the new test with its current high-throughput molecular instruments throughout the country.

» Acquisitions and Mergers:

• Dec-2021: Pfizer entered into an agreement to acquire Arena Pharmaceuticals, a clinical-stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases. This acquisition aimed to match the capabilities and expertise in Immunology and Inflammation and develop potential therapies for patients with debilitating immuno-inflammatory diseases with a requirement for more effective treatment options.

» Approvals and Trials:

• Dec-2021: Pfizer received approval from U.S. Food and Drug Administration (FDA) for emergency use of PAXLOVID. This approval aimed to treat mild-to-moderate COVID-19 in adults and pediatric patients with positive outcomes of direct SARS-CoV-2 viral testing, and patients that are at greater risk for progression to severe COVID-19, comprising death or hospitalization. The treatment consists of nirmatrelvir, a novel main protease (Mpro) inhibitor originating in Pfizer’s laboratories, which was notably created to block the activity of the SARS-CoV-2 Mpro, an enzyme that the coronavirus required to replicate.
• Mar-2020: Abbott received a U.S. Food and Drug Administration (FDA) approval for Emergency Use Authorization (EUA). This approval aimed for companies to perform the molecular test for novel coronavirus (COVID-19). Abbott RealTime SARS-CoV-2 EUA tests are used on the company's m2000 RealTime System. Abbott is delivering 150,000 Abbott RealTime SARS-CoV EUA tests to current consumers in the U.S.
• Mar-2020: Abbott received a U.S. Food and Drug Administration (FDA) approval for the ID NOW platform. ID NOW platform is small, lightweight (6.6 pounds) and portable (the size of a small toaster), and utilizes molecular technology, which is valued by clinicians and the scientific community for its greater level of accuracy. This approval aimed to run the test on the company's ID NOW platform, delivering quick outcomes in a broad range of healthcare settings like physicians' offices, urgent care clinics, and hospital emergency departments.

Scope of the Study

Market Segments Covered in the Report:

By Product

• Reagents & Consumables
• Instrument

By Infection Type

• Urinary Tract Infections (UTI)
• Hospital Acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Others

By Application

• Drug-Resistance Testing
• Disease Testing

By Test Type

• Molecular Diagnostics
• Immunoassay
• Urinalysis

By End User

• Hospital
• Standalone Laboratories
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Bayer AG (Bayer Schering Pharma AG)
• Danaher Corporation
• Becton, Dickinson and Company
• Hologic, Inc.
• Ecolab, Inc.
• Pfizer, Inc.
• Steris PLC
• Johnson & Johnson
• Abbott Laboratories
• Merck Group

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Hospital-Acquired Infection Diagnostics Market, by Product
1.4.2 Global Hospital-Acquired Infection Diagnostics Market, by Infection Type
1.4.3 Global Hospital-Acquired Infection Diagnostics Market, by Application
1.4.4 Global Hospital-Acquired Infection Diagnostics Market, by Test Type
1.4.5 Global Hospital-Acquired Infection Diagnostics Market, by End User
1.4.6 Global Hospital-Acquired Infection Diagnostics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Global Hospital-Acquired Infection Diagnostics Market by Product
4.1 Global Reagents & Consumables Market by Region
4.2 Global Instrument Market by Region

Chapter 5. Global Hospital-Acquired Infection Diagnostics Market by Infection Type
5.1 Global Urinary Tract Infections (UTI) Market by Region
5.2 Global Hospital Acquired Pneumonia Market by Region
5.3 Global Bloodstream Infections Market by Region
5.4 Global Surgical Site Infections Market by Region
5.5 Global Gastrointestinal Infections Market by Region
5.6 Global Others Market by Region

Chapter 6. Global Hospital-Acquired Infection Diagnostics Market by Application
6.1 Global Drug-Resistance Testing Market by Region
6.2 Global Disease Testing Market by Region

Chapter 7. Global Hospital-Acquired Infection Diagnostics Market by Test Type
7.1 Global Molecular Diagnostics Market by Region
7.2 Global Immunoassay Market by Region
7.3 Global Urinalysis Market by Region

Chapter 8. Global Hospital-Acquired Infection Diagnostics Market by End User
8.1 Global Hospital Market by Region
8.2 Global Standalone Laboratories Market by Region
8.3 Global Others Market by Region

Chapter 9. Global Hospital-Acquired Infection Diagnostics Market by Region
9.1 North America Hospital-Acquired Infection Diagnostics Market
9.1.1 North America Hospital-Acquired Infection Diagnostics Market by Product
9.1.1.1 North America Reagents & Consumables Market by Country
9.1.1.2 North America Instrument Market by Country
9.1.2 North America Hospital-Acquired Infection Diagnostics Market by Infection Type
9.1.2.1 North America Urinary Tract Infections (UTI) Market by Country
9.1.2.2 North America Hospital Acquired Pneumonia Market by Country
9.1.2.3 North America Bloodstream Infections Market by Country
9.1.2.4 North America Surgical Site Infections Market by Country
9.1.2.5 North America Gastrointestinal Infections Market by Country
9.1.2.6 North America Others Market by Country
9.1.3 North America Hospital-Acquired Infection Diagnostics Market by Application
9.1.3.1 North America Drug-Resistance Testing Market by Country
9.1.3.2 North America Disease Testing Market by Country
9.1.4 North America Hospital-Acquired Infection Diagnostics Market by Test Type
9.1.4.1 North America Molecular Diagnostics Market by Country
9.1.4.2 North America Immunoassay Market by Country
9.1.4.3 North America Urinalysis Market by Country
9.1.5 North America Hospital-Acquired Infection Diagnostics Market by End User
9.1.5.1 North America Hospital Market by Country
9.1.5.2 North America Standalone Laboratories Market by Country
9.1.5.3 North America Others Market by Country
9.1.6 North America Hospital-Acquired Infection Diagnostics Market by Country
9.1.6.1 US Hospital-Acquired Infection Diagnostics Market
9.1.6.1.1 US Hospital-Acquired Infection Diagnostics Market by Product
9.1.6.1.2 US Hospital-Acquired Infection Diagnostics Market by Infection Type
9.1.6.1.3 US Hospital-Acquired Infection Diagnostics Market by Application
9.1.6.1.4 US Hospital-Acquired Infection Diagnostics Market by Test Type
9.1.6.1.5 US Hospital-Acquired Infection Diagnostics Market by End User
9.1.6.2 Canada Hospital-Acquired Infection Diagnostics Market
9.1.6.2.1 Canada Hospital-Acquired Infection Diagnostics Market by Product
9.1.6.2.2 Canada Hospital-Acquired Infection Diagnostics Market by Infection Type
9.1.6.2.3 Canada Hospital-Acquired Infection Diagnostics Market by Application
9.1.6.2.4 Canada Hospital-Acquired Infection Diagnostics Market by Test Type
9.1.6.2.5 Canada Hospital-Acquired Infection Diagnostics Market by End User
9.1.6.3 Mexico Hospital-Acquired Infection Diagnostics Market
9.1.6.3.1 Mexico Hospital-Acquired Infection Diagnostics Market by Product
9.1.6.3.2 Mexico Hospital-Acquired Infection Diagnostics Market by Infection Type
9.1.6.3.3 Mexico Hospital-Acquired Infection Diagnostics Market by Application
9.1.6.3.4 Mexico Hospital-Acquired Infection Diagnostics Market by Test Type
9.1.6.3.5 Mexico Hospital-Acquired Infection Diagnostics Market by End User
9.1.6.4 Rest of North America Hospital-Acquired Infection Diagnostics Market
9.1.6.4.1 Rest of North America Hospital-Acquired Infection Diagnostics Market by Product
9.1.6.4.2 Rest of North America Hospital-Acquired Infection Diagnostics Market by Infection Type
9.1.6.4.3 Rest of North America Hospital-Acquired Infection Diagnostics Market by Application
9.1.6.4.4 Rest of North America Hospital-Acquired Infection Diagnostics Market by Test Type
9.1.6.4.5 Rest of North America Hospital-Acquired Infection Diagnostics Market by End User
9.2 Europe Hospital-Acquired Infection Diagnostics Market
9.2.1 Europe Hospital-Acquired Infection Diagnostics Market by Product
9.2.1.1 Europe Reagents & Consumables Market by Country
9.2.1.2 Europe Instrument Market by Country
9.2.2 Europe Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.2.1 Europe Urinary Tract Infections (UTI) Market by Country
9.2.2.2 Europe Hospital Acquired Pneumonia Market by Country
9.2.2.3 Europe Bloodstream Infections Market by Country
9.2.2.4 Europe Surgical Site Infections Market by Country
9.2.2.5 Europe Gastrointestinal Infections Market by Country
9.2.2.6 Europe Others Market by Country
9.2.3 Europe Hospital-Acquired Infection Diagnostics Market by Application
9.2.3.1 Europe Drug-Resistance Testing Market by Country
9.2.3.2 Europe Disease Testing Market by Country
9.2.4 Europe Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.4.1 Europe Molecular Diagnostics Market by Country
9.2.4.2 Europe Immunoassay Market by Country
9.2.4.3 Europe Urinalysis Market by Country
9.2.5 Europe Hospital-Acquired Infection Diagnostics Market by End User
9.2.5.1 Europe Hospital Market by Country
9.2.5.2 Europe Standalone Laboratories Market by Country
9.2.5.3 Europe Others Market by Country
9.2.6 Europe Hospital-Acquired Infection Diagnostics Market by Country
9.2.6.1 Germany Hospital-Acquired Infection Diagnostics Market
9.2.6.1.1 Germany Hospital-Acquired Infection Diagnostics Market by Product
9.2.6.1.2 Germany Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.6.1.3 Germany Hospital-Acquired Infection Diagnostics Market by Application
9.2.6.1.4 Germany Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.6.1.5 Germany Hospital-Acquired Infection Diagnostics Market by End User
9.2.6.2 UK Hospital-Acquired Infection Diagnostics Market
9.2.6.2.1 UK Hospital-Acquired Infection Diagnostics Market by Product
9.2.6.2.2 UK Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.6.2.3 UK Hospital-Acquired Infection Diagnostics Market by Application
9.2.6.2.4 UK Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.6.2.5 UK Hospital-Acquired Infection Diagnostics Market by End User
9.2.6.3 France Hospital-Acquired Infection Diagnostics Market
9.2.6.3.1 France Hospital-Acquired Infection Diagnostics Market by Product
9.2.6.3.2 France Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.6.3.3 France Hospital-Acquired Infection Diagnostics Market by Application
9.2.6.3.4 France Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.6.3.5 France Hospital-Acquired Infection Diagnostics Market by End User
9.2.6.4 Russia Hospital-Acquired Infection Diagnostics Market
9.2.6.4.1 Russia Hospital-Acquired Infection Diagnostics Market by Product
9.2.6.4.2 Russia Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.6.4.3 Russia Hospital-Acquired Infection Diagnostics Market by Application
9.2.6.4.4 Russia Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.6.4.5 Russia Hospital-Acquired Infection Diagnostics Market by End User
9.2.6.5 Spain Hospital-Acquired Infection Diagnostics Market
9.2.6.5.1 Spain Hospital-Acquired Infection Diagnostics Market by Product
9.2.6.5.2 Spain Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.6.5.3 Spain Hospital-Acquired Infection Diagnostics Market by Application
9.2.6.5.4 Spain Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.6.5.5 Spain Hospital-Acquired Infection Diagnostics Market by End User
9.2.6.6 Italy Hospital-Acquired Infection Diagnostics Market
9.2.6.6.1 Italy Hospital-Acquired Infection Diagnostics Market by Product
9.2.6.6.2 Italy Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.6.6.3 Italy Hospital-Acquired Infection Diagnostics Market by Application
9.2.6.6.4 Italy Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.6.6.5 Italy Hospital-Acquired Infection Diagnostics Market by End User
9.2.6.7 Rest of Europe Hospital-Acquired Infection Diagnostics Market
9.2.6.7.1 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Product
9.2.6.7.2 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.6.7.3 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Application
9.2.6.7.4 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.6.7.5 Rest of Europe Hospital-Acquired Infection Diagnostics Market by End User
9.3 Asia Pacific Hospital-Acquired Infection Diagnostics Market
9.3.1 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Product
9.3.1.1 Asia Pacific Reagents & Consumables Market by Country
9.3.1.2 Asia Pacific Instrument Market by Country
9.3.2 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.2.1 Asia Pacific Urinary Tract Infections (UTI) Market by Country
9.3.2.2 Asia Pacific Hospital Acquired Pneumonia Market by Country
9.3.2.3 Asia Pacific Bloodstream Infections Market by Country
9.3.2.4 Asia Pacific Surgical Site Infections Market by Country
9.3.2.5 Asia Pacific Gastrointestinal Infections Market by Country
9.3.2.6 Asia Pacific Others Market by Country
9.3.3 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Application
9.3.3.1 Asia Pacific Drug-Resistance Testing Market by Country
9.3.3.2 Asia Pacific Disease Testing Market by Country
9.3.4 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.4.1 Asia Pacific Molecular Diagnostics Market by Country
9.3.4.2 Asia Pacific Immunoassay Market by Country
9.3.4.3 Asia Pacific Urinalysis Market by Country
9.3.5 Asia Pacific Hospital-Acquired Infection Diagnostics Market by End User
9.3.5.1 Asia Pacific Hospital Market by Country
9.3.5.2 Asia Pacific Standalone Laboratories Market by Country
9.3.5.3 Asia Pacific Others Market by Country
9.3.6 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Country
9.3.6.1 China Hospital-Acquired Infection Diagnostics Market
9.3.6.1.1 China Hospital-Acquired Infection Diagnostics Market by Product
9.3.6.1.2 China Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.6.1.3 China Hospital-Acquired Infection Diagnostics Market by Application
9.3.6.1.4 China Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.6.1.5 China Hospital-Acquired Infection Diagnostics Market by End User
9.3.6.2 Japan Hospital-Acquired Infection Diagnostics Market
9.3.6.2.1 Japan Hospital-Acquired Infection Diagnostics Market by Product
9.3.6.2.2 Japan Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.6.2.3 Japan Hospital-Acquired Infection Diagnostics Market by Application
9.3.6.2.4 Japan Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.6.2.5 Japan Hospital-Acquired Infection Diagnostics Market by End User
9.3.6.3 India Hospital-Acquired Infection Diagnostics Market
9.3.6.3.1 India Hospital-Acquired Infection Diagnostics Market by Product
9.3.6.3.2 India Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.6.3.3 India Hospital-Acquired Infection Diagnostics Market by Application
9.3.6.3.4 India Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.6.3.5 India Hospital-Acquired Infection Diagnostics Market by End User
9.3.6.4 South Korea Hospital-Acquired Infection Diagnostics Market
9.3.6.4.1 South Korea Hospital-Acquired Infection Diagnostics Market by Product
9.3.6.4.2 South Korea Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.6.4.3 South Korea Hospital-Acquired Infection Diagnostics Market by Application
9.3.6.4.4 South Korea Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.6.4.5 South Korea Hospital-Acquired Infection Diagnostics Market by End User
9.3.6.5 Singapore Hospital-Acquired Infection Diagnostics Market
9.3.6.5.1 Singapore Hospital-Acquired Infection Diagnostics Market by Product
9.3.6.5.2 Singapore Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.6.5.3 Singapore Hospital-Acquired Infection Diagnostics Market by Application
9.3.6.5.4 Singapore Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.6.5.5 Singapore Hospital-Acquired Infection Diagnostics Market by End User
9.3.6.6 Malaysia Hospital-Acquired Infection Diagnostics Market
9.3.6.6.1 Malaysia Hospital-Acquired Infection Diagnostics Market by Product
9.3.6.6.2 Malaysia Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.6.6.3 Malaysia Hospital-Acquired Infection Diagnostics Market by Application
9.3.6.6.4 Malaysia Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.6.6.5 Malaysia Hospital-Acquired Infection Diagnostics Market by End User
9.3.6.7 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market
9.3.6.7.1 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Product
9.3.6.7.2 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.6.7.3 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Application
9.3.6.7.4 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.6.7.5 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by End User
9.4 LAMEA Hospital-Acquired Infection Diagnostics Market
9.4.1 LAMEA Hospital-Acquired Infection Diagnostics Market by Product
9.4.1.1 LAMEA Reagents & Consumables Market by Country
9.4.1.2 LAMEA Instrument Market by Country
9.4.2 LAMEA Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.2.1 LAMEA Urinary Tract Infections (UTI) Market by Country
9.4.2.2 LAMEA Hospital Acquired Pneumonia Market by Country
9.4.2.3 LAMEA Bloodstream Infections Market by Country
9.4.2.4 LAMEA Surgical Site Infections Market by Country
9.4.2.5 LAMEA Gastrointestinal Infections Market by Country
9.4.2.6 LAMEA Others Market by Country
9.4.3 LAMEA Hospital-Acquired Infection Diagnostics Market by Application
9.4.3.1 LAMEA Drug-Resistance Testing Market by Country
9.4.3.2 LAMEA Disease Testing Market by Country
9.4.4 LAMEA Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.4.1 LAMEA Molecular Diagnostics Market by Country
9.4.4.2 LAMEA Immunoassay Market by Country
9.4.4.3 LAMEA Urinalysis Market by Country
9.4.5 LAMEA Hospital-Acquired Infection Diagnostics Market by End User
9.4.5.1 LAMEA Hospital Market by Country
9.4.5.2 LAMEA Standalone Laboratories Market by Country
9.4.5.3 LAMEA Others Market by Country
9.4.6 LAMEA Hospital-Acquired Infection Diagnostics Market by Country
9.4.6.1 Brazil Hospital-Acquired Infection Diagnostics Market
9.4.6.1.1 Brazil Hospital-Acquired Infection Diagnostics Market by Product
9.4.6.1.2 Brazil Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.6.1.3 Brazil Hospital-Acquired Infection Diagnostics Market by Application
9.4.6.1.4 Brazil Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.6.1.5 Brazil Hospital-Acquired Infection Diagnostics Market by End User
9.4.6.2 Argentina Hospital-Acquired Infection Diagnostics Market
9.4.6.2.1 Argentina Hospital-Acquired Infection Diagnostics Market by Product
9.4.6.2.2 Argentina Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.6.2.3 Argentina Hospital-Acquired Infection Diagnostics Market by Application
9.4.6.2.4 Argentina Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.6.2.5 Argentina Hospital-Acquired Infection Diagnostics Market by End User
9.4.6.3 UAE Hospital-Acquired Infection Diagnostics Market
9.4.6.3.1 UAE Hospital-Acquired Infection Diagnostics Market by Product
9.4.6.3.2 UAE Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.6.3.3 UAE Hospital-Acquired Infection Diagnostics Market by Application
9.4.6.3.4 UAE Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.6.3.5 UAE Hospital-Acquired Infection Diagnostics Market by End User
9.4.6.4 Saudi Arabia Hospital-Acquired Infection Diagnostics Market
9.4.6.4.1 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Product
9.4.6.4.2 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.6.4.3 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Application
9.4.6.4.4 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.6.4.5 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by End User
9.4.6.5 South Africa Hospital-Acquired Infection Diagnostics Market
9.4.6.5.1 South Africa Hospital-Acquired Infection Diagnostics Market by Product
9.4.6.5.2 South Africa Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.6.5.3 South Africa Hospital-Acquired Infection Diagnostics Market by Application
9.4.6.5.4 South Africa Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.6.5.5 South Africa Hospital-Acquired Infection Diagnostics Market by End User
9.4.6.6 Nigeria Hospital-Acquired Infection Diagnostics Market
9.4.6.6.1 Nigeria Hospital-Acquired Infection Diagnostics Market by Product
9.4.6.6.2 Nigeria Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.6.6.3 Nigeria Hospital-Acquired Infection Diagnostics Market by Application
9.4.6.6.4 Nigeria Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.6.6.5 Nigeria Hospital-Acquired Infection Diagnostics Market by End User
9.4.6.7 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market
9.4.6.7.1 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Product
9.4.6.7.2 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.6.7.3 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Application
9.4.6.7.4 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.6.7.5 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by End User

Chapter 10. Company Profiles
10.1 Bayer AG (Bayer Schering Pharma AG)
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent Strategies and Developments
10.1.5.1 Partnerships, Collaborations and Agreements
10.2 Danaher Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.3 Becton, Dickinson and Company
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.1 Recent Strategies and Developments
10.3.1.1 Partnerships, Collaborations and Agreements
10.3.1.2 Product Launches and Product Expansions
10.4 Hologic, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent Strategies and Developments
10.4.5.1 Partnerships, Collaborations and Agreements
10.4.5.2 Product Launches and Product Expansions
10.5 Ecolab, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent Strategies and Developments
10.5.5.1 Product Launches and Product Expansions:
10.5.5.2 Geographical Expansions:
10.6 Pfizer, Inc.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Regional & Segmental Analysis
10.6.4 Research & Development Expense
10.6.5 Recent Strategies and Developments
10.6.5.1 Approvals and Trials:
10.6.5.2 Acquisitions and Mergers
10.7 Steris PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.8 Johnson & Johnson
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental &Regional Analysis
10.8.4 Research & Development Expenses
10.9 Abbott Laboratories
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent Strategies and Developments
10.9.5.1 Approvals and Trials:
10.9.5.2 Product Launches and Product Expansions:
10.10. Merck Group
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent Strategies and Developments
10.10.5.1 Partnerships, Collaborations and Agreements

TABLE 1 Global Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 Global Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Hospital-Acquired Infection Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Hospital-Acquired Infection Diagnostics Market
TABLE 5 Acquisition and Mergers– Hospital-Acquired Infection Diagnostics Market
TABLE 6 Approvals and Trials - Hospital-Acquired Infection Diagnostics Market
TABLE 7 Global Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 8 Global Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 9 Global Reagents & Consumables Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Reagents & Consumables Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Instrument Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Instrument Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 14 Global Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 15 Global Urinary Tract Infections (UTI) Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Urinary Tract Infections (UTI) Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Hospital Acquired Pneumonia Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Hospital Acquired Pneumonia Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Bloodstream Infections Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Bloodstream Infections Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Surgical Site Infections Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Surgical Site Infections Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Gastrointestinal Infections Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Gastrointestinal Infections Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 28 Global Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 29 Global Drug-Resistance Testing Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Drug-Resistance Testing Market by Region, 2022 - 2028, USD Million
TABLE 31 Global Disease Testing Market by Region, 2018 - 2021, USD Million
TABLE 32 Global Disease Testing Market by Region, 2022 - 2028, USD Million
TABLE 33 Global Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 34 Global Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 35 Global Molecular Diagnostics Market by Region, 2018 - 2021, USD Million
TABLE 36 Global Molecular Diagnostics Market by Region, 2022 - 2028, USD Million
TABLE 37 Global Immunoassay Market by Region, 2018 - 2021, USD Million
TABLE 38 Global Immunoassay Market by Region, 2022 - 2028, USD Million
TABLE 39 Global Urinalysis Market by Region, 2018 - 2021, USD Million
TABLE 40 Global Urinalysis Market by Region, 2022 - 2028, USD Million
TABLE 41 Global Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 42 Global Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 43 Global Hospital Market by Region, 2018 - 2021, USD Million
TABLE 44 Global Hospital Market by Region, 2022 - 2028, USD Million
TABLE 45 Global Standalone Laboratories Market by Region, 2018 - 2021, USD Million
TABLE 46 Global Standalone Laboratories Market by Region, 2022 - 2028, USD Million
TABLE 47 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 48 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 49 Global Hospital-Acquired Infection Diagnostics Market by Region, 2018 - 2021, USD Million
TABLE 50 Global Hospital-Acquired Infection Diagnostics Market by Region, 2022 - 2028, USD Million
TABLE 51 North America Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 52 North America Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 53 North America Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 54 North America Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 55 North America Reagents & Consumables Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Reagents & Consumables Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Instrument Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Instrument Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 60 North America Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 61 North America Urinary Tract Infections (UTI) Market by Country, 2018 - 2021, USD Million
TABLE 62 North America Urinary Tract Infections (UTI) Market by Country, 2022 - 2028, USD Million
TABLE 63 North America Hospital Acquired Pneumonia Market by Country, 2018 - 2021, USD Million
TABLE 64 North America Hospital Acquired Pneumonia Market by Country, 2022 - 2028, USD Million
TABLE 65 North America Bloodstream Infections Market by Country, 2018 - 2021, USD Million
TABLE 66 North America Bloodstream Infections Market by Country, 2022 - 2028, USD Million
TABLE 67 North America Surgical Site Infections Market by Country, 2018 - 2021, USD Million
TABLE 68 North America Surgical Site Infections Market by Country, 2022 - 2028, USD Million
TABLE 69 North America Gastrointestinal Infections Market by Country, 2018 - 2021, USD Million
TABLE 70 North America Gastrointestinal Infections Market by Country, 2022 - 2028, USD Million
TABLE 71 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 72 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 73 North America Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 74 North America Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 75 North America Drug-Resistance Testing Market by Country, 2018 - 2021, USD Million
TABLE 76 North America Drug-Resistance Testing Market by Country, 2022 - 2028, USD Million
TABLE 77 North America Disease Testing Market by Country, 2018 - 2021, USD Million
TABLE 78 North America Disease Testing Market by Country, 2022 - 2028, USD Million
TABLE 79 North America Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 80 North America Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 81 North America Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 82 North America Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 83 North America Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 84 North America Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 85 North America Urinalysis Market by Country, 2018 - 2021, USD Million
TABLE 86 North America Urinalysis Market by Country, 2022 - 2028, USD Million
TABLE 87 North America Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 88 North America Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 89 North America Hospital Market by Country, 2018 - 2021, USD Million
TABLE 90 North America Hospital Market by Country, 2022 - 2028, USD Million
TABLE 91 North America Standalone Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 92 North America Standalone Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 93 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 94 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 95 North America Hospital-Acquired Infection Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 96 North America Hospital-Acquired Infection Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 97 US Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 98 US Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 99 US Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 100 US Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 101 US Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 102 US Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 103 US Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 104 US Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 105 US Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 106 US Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 107 US Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 108 US Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 109 Canada Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 110 Canada Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 111 Canada Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 112 Canada Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 113 Canada Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 114 Canada Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 115 Canada Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 116 Canada Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 117 Canada Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 118 Canada Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 119 Canada Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 120 Canada Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 121 Mexico Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 122 Mexico Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 123 Mexico Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 124 Mexico Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 125 Mexico Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 126 Mexico Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 127 Mexico Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 128 Mexico Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 129 Mexico Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 130 Mexico Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 131 Mexico Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 132 Mexico Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 133 Rest of North America Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 134 Rest of North America Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 135 Rest of North America Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 136 Rest of North America Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 137 Rest of North America Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 138 Rest of North America Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 139 Rest of North America Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 140 Rest of North America Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 141 Rest of North America Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 142 Rest of North America Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 143 Rest of North America Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 144 Rest of North America Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 145 Europe Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 146 Europe Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 147 Europe Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 148 Europe Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 149 Europe Reagents & Consumables Market by Country, 2018 - 2021, USD Million
TABLE 150 Europe Reagents & Consumables Market by Country, 2022 - 2028, USD Million
TABLE 151 Europe Instrument Market by Country, 2018 - 2021, USD Million
TABLE 152 Europe Instrument Market by Country, 2022 - 2028, USD Million
TABLE 153 Europe Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 154 Europe Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 155 Europe Urinary Tract Infections (UTI) Market by Country, 2018 - 2021, USD Million
TABLE 156 Europe Urinary Tract Infections (UTI) Market by Country, 2022 - 2028, USD Million
TABLE 157 Europe Hospital Acquired Pneumonia Market by Country, 2018 - 2021, USD Million
TABLE 158 Europe Hospital Acquired Pneumonia Market by Country, 2022 - 2028, USD Million
TABLE 159 Europe Bloodstream Infections Market by Country, 2018 - 2021, USD Million
TABLE 160 Europe Bloodstream Infections Market by Country, 2022 - 2028, USD Million
TABLE 161 Europe Surgical Site Infections Market by Country, 2018 - 2021, USD Million
TABLE 162 Europe Surgical Site Infections Market by Country, 2022 - 2028, USD Million
TABLE 163 Europe Gastrointestinal Infections Market by Country, 2018 - 2021, USD Million
TABLE 164 Europe Gastrointestinal Infections Market by Country, 2022 - 2028, USD Million
TABLE 165 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 166 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 167 Europe Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 168 Europe Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 169 Europe Drug-Resistance Testing Market by Country, 2018 - 2021, USD Million
TABLE 170 Europe Drug-Resistance Testing Market by Country, 2022 - 2028, USD Million
TABLE 171 Europe Disease Testing Market by Country, 2018 - 2021, USD Million
TABLE 172 Europe Disease Testing Market by Country, 2022 - 2028, USD Million
TABLE 173 Europe Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 174 Europe Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 175 Europe Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 176 Europe Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 177 Europe Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 178 Europe Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 179 Europe Urinalysis Market by Country, 2018 - 2021, USD Million
TABLE 180 Europe Urinalysis Market by Country, 2022 - 2028, USD Million
TABLE 181 Europe Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 182 Europe Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 183 Europe Hospital Market by Country, 2018 - 2021, USD Million
TABLE 184 Europe Hospital Market by Country, 2022 - 2028, USD Million
TABLE 185 Europe Standalone Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 186 Europe Standalone Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 187 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 188 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 189 Europe Hospital-Acquired Infection Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 190 Europe Hospital-Acquired Infection Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 191 Germany Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 192 Germany Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 193 Germany Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 194 Germany Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 195 Germany Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 196 Germany Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 197 Germany Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 198 Germany Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 199 Germany Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 200 Germany Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 201 Germany Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 202 Germany Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 203 UK Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 204 UK Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 205 UK Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 206 UK Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 207 UK Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 208 UK Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 209 UK Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 210 UK Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 211 UK Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 212 UK Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 213 UK Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 214 UK Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 215 France Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 216 France Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 217 France Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 218 France Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 219 France Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 220 France Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 221 France Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 222 France Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 223 France Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 224 France Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 225 France Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 226 France Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 227 Russia Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 228 Russia Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 229 Russia Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 230 Russia Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 231 Russia Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 232 Russia Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 233 Russia Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 234 Russia Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 235 Russia Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 236 Russia Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 237 Russia Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 238 Russia Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 239 Spain Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 240 Spain Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 241 Spain Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 242 Spain Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 243 Spain Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 244 Spain Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 245 Spain Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 246 Spain Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 247 Spain Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 248 Spain Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 249 Spain Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 250 Spain Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 251 Italy Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 252 Italy Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 253 Italy Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 254 Italy Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 255 Italy Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 256 Italy Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 257 Italy Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 258 Italy Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 259 Italy Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 260 Italy Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 261 Italy Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 262 Italy Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 263 Rest of Europe Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 264 Rest of Europe Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 265 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 266 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 267 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 268 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 269 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 270 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 271 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 272 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 273 Rest of Europe Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 274 Rest of Europe Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 275 Asia Pacific Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 276 Asia Pacific Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 277 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 278 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 279 Asia Pacific Reagents & Consumables Market by Country, 2018 - 2021, USD Million
TABLE 280 Asia Pacific Reagents & Consumables Market by Country, 2022 - 2028, USD Million
TABLE 281 Asia Pacific Instrument Market by Country, 2018 - 2021, USD Million
TABLE 282 Asia Pacific Instrument Market by Country, 2022 - 2028, USD Million
TABLE 283 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 284 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 285 Asia Pacific Urinary Tract Infections (UTI) Market by Country, 2018 - 2021, USD Million
TABLE 286 Asia Pacific Urinary Tract Infections (UTI) Market by Country, 2022 - 2028, USD Million
TABLE 287 Asia Pacific Hospital Acquired Pneumonia Market by Country, 2018 - 2021, USD Million
TABLE 288 Asia Pacific Hospital Acquired Pneumonia Market by Country, 2022 - 2028, USD Million
TABLE 289 Asia Pacific Bloodstream Infections Market by Country, 2018 - 2021, USD Million
TABLE 290 Asia Pacific Bloodstream Infections Market by Country, 2022 - 2028, USD Million
TABLE 291 Asia Pacific Surgical Site Infections Market by Country, 2018 - 2021, USD Million
TABLE 292 Asia Pacific Surgical Site Infections Market by Country, 2022 - 2028, USD Million
TABLE 293 Asia Pacific Gastrointestinal Infections Market by Country, 2018 - 2021, USD Million
TABLE 294 Asia Pacific Gastrointestinal Infections Market by Country, 2022 - 2028, USD Million
TABLE 295 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 296 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 297 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 298 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 299 Asia Pacific Drug-Resistance Testing Market by Country, 2018 - 2021, USD Million
TABLE 300 Asia Pacific Drug-Resistance Testing Market by Country, 2022 - 2028, USD Million
TABLE 301 Asia Pacific Disease Testing Market by Country, 2018 - 2021, USD Million
TABLE 302 Asia Pacific Disease Testing Market by Country, 2022 - 2028, USD Million
TABLE 303 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 304 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 305 Asia Pacific Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 306 Asia Pacific Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 307 Asia Pacific Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 308 Asia Pacific Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 309 Asia Pacific Urinalysis Market by Country, 2018 - 2021, USD Million
TABLE 310 Asia Pacific Urinalysis Market by Country, 2022 - 2028, USD Million
TABLE 311 Asia Pacific Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 312 Asia Pacific Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 313 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Million
TABLE 314 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Million
TABLE 315 Asia Pacific Standalone Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 316 Asia Pacific Standalone Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 317 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 318 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 319 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 320 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 321 China Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 322 China Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 323 China Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 324 China Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 325 China Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 326 China Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 327 China Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 328 China Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 329 China Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 330 China Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 331 China Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 332 China Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 333 Japan Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 334 Japan Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 335 Japan Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 336 Japan Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 337 Japan Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 338 Japan Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 339 Japan Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 340 Japan Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 341 Japan Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 342 Japan Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 343 Japan Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 344 Japan Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 345 India Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 346 India Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 347 India Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 348 India Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 349 India Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 350 India Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 351 India Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 352 India Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 353 India Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 354 India Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 355 India Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 356 India Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 357 South Korea Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 358 South Korea Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 359 South Korea Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 360 South Korea Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 361 South Korea Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 362 South Korea Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 363 South Korea Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 364 South Korea Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 365 South Korea Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 366 South Korea Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 367 South Korea Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 368 South Korea Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 369 Singapore Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 370 Singapore Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 371 Singapore Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 372 Singapore Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 373 Singapore Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 374 Singapore Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 375 Singapore Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 376 Singapore Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 377 Singapore Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 378 Singapore Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 379 Singapore Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 380 Singapore Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 381 Malaysia Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 382 Malaysia Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 383 Malaysia Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 384 Malaysia Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 385 Malaysia Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 386 Malaysia Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 387 Malaysia Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 388 Malaysia Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 389 Malaysia Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 390 Malaysia Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 391 Malaysia Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 392 Malaysia Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 393 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 394 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 395 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 396 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 397 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 398 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 399 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 400 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 401 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 402 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 403 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 404 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 405 LAMEA Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 406 LAMEA Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 407 LAMEA Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 408 LAMEA Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 409 LAMEA Reagents & Consumables Market by Country, 2018 - 2021, USD Million
TABLE 410 LAMEA Reagents & Consumables Market by Country, 2022 - 2028, USD Million
TABLE 411 LAMEA Instrument Market by Country, 2018 - 2021, USD Million
TABLE 412 LAMEA Instrument Market by Country, 2022 - 2028, USD Million
TABLE 413 LAMEA Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 414 LAMEA Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 415 LAMEA Urinary Tract Infections (UTI) Market by Country, 2018 - 2021, USD Million
TABLE 416 LAMEA Urinary Tract Infections (UTI) Market by Country, 2022 - 2028, USD Million
TABLE 417 LAMEA Hospital Acquired Pneumonia Market by Country, 2018 - 2021, USD Million
TABLE 418 LAMEA Hospital Acquired Pneumonia Market by Country, 2022 - 2028, USD Million
TABLE 419 LAMEA Bloodstream Infections Market by Country, 2018 - 2021, USD Million
TABLE 420 LAMEA Bloodstream Infections Market by Country, 2022 - 2028, USD Million
TABLE 421 LAMEA Surgical Site Infections Market by Country, 2018 - 2021, USD Million
TABLE 422 LAMEA Surgical Site Infections Market by Country, 2022 - 2028, USD Million
TABLE 423 LAMEA Gastrointestinal Infections Market by Country, 2018 - 2021, USD Million
TABLE 424 LAMEA Gastrointestinal Infections Market by Country, 2022 - 2028, USD Million
TABLE 425 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 426 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 427 LAMEA Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 428 LAMEA Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 429 LAMEA Drug-Resistance Testing Market by Country, 2018 - 2021, USD Million
TABLE 430 LAMEA Drug-Resistance Testing Market by Country, 2022 - 2028, USD Million
TABLE 431 LAMEA Disease Testing Market by Country, 2018 - 2021, USD Million
TABLE 432 LAMEA Disease Testing Market by Country, 2022 - 2028, USD Million
TABLE 433 LAMEA Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 434 LAMEA Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 435 LAMEA Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 436 LAMEA Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 437 LAMEA Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 438 LAMEA Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 439 LAMEA Urinalysis Market by Country, 2018 - 2021, USD Million
TABLE 440 LAMEA Urinalysis Market by Country, 2022 - 2028, USD Million
TABLE 441 LAMEA Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 442 LAMEA Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 443 LAMEA Hospital Market by Country, 2018 - 2021, USD Million
TABLE 444 LAMEA Hospital Market by Country, 2022 - 2028, USD Million
TABLE 445 LAMEA Standalone Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 446 LAMEA Standalone Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 447 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 448 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 449 LAMEA Hospital-Acquired Infection Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 450 LAMEA Hospital-Acquired Infection Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 451 Brazil Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 452 Brazil Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 453 Brazil Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 454 Brazil Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 455 Brazil Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 456 Brazil Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 457 Brazil Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 458 Brazil Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 459 Brazil Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 460 Brazil Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 461 Brazil Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 462 Brazil Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 463 Argentina Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 464 Argentina Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 465 Argentina Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 466 Argentina Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 467 Argentina Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 468 Argentina Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 469 Argentina Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 470 Argentina Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 471 Argentina Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 472 Argentina Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 473 Argentina Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 474 UAE Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 475 UAE Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 476 UAE Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 477 UAE Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 478 UAE Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 479 UAE Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 480 UAE Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 481 UAE Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 482 UAE Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 483 UAE Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 484 UAE Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 485 UAE Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 486 Saudi Arabia Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 487 Saudi Arabia Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 488 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 489 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 490 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 491 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 492 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 493 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 494 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 495 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 496 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 497 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 498 South Africa Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 499 South Africa Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 500 South Africa Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 501 South Africa Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 502 South Africa Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 503 South Africa Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 504 South Africa Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 505 South Africa Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 506 South Africa Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 507 South Africa Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 508 South Africa Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 509 South Africa Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 510 Nigeria Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 511 Nigeria Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 512 Nigeria Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 513 Nigeria Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 514 Nigeria Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 515 Nigeria Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 516 Nigeria Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 517 Nigeria Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 518 Nigeria Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 519 Nigeria Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 520 Nigeria Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 521 Nigeria Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 522 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 523 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 524 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 525 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 526 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 527 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 528 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 529 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 530 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 531 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 532 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 533 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 534 Key Information – Bayer AG
TABLE 535 Key Information – Danaher Corporation
TABLE 536 Key information – Becton, Dickinson and Company
TABLE 537 Key information – Hologic, Inc.
TABLE 538 Key Information – Ecolab, Inc.
TABLE 539 Key Information – Pfizer, Inc.
TABLE 540 key information – Steris PLC
TABLE 541 Key information – Johnson & Johnson
TABLE 542 Key Information – Abbott Laboratories
TABLE 543 key Information – Merck GrouP

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Global Hospital-Acquired Infection Diagnostics Market Share by Product, 2021
FIG 5 Global Hospital-Acquired Infection Diagnostics Market Share by Product, 2028
FIG 6 Global Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2028, USD Million
FIG 7 Global Hospital-Acquired Infection Diagnostics Market Share by Infection Type, 2021
FIG 8 Global Hospital-Acquired Infection Diagnostics Market Share by Infection Type, 2028
FIG 9 Global Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2028, USD Million
FIG 10 Global Hospital-Acquired Infection Diagnostics Market Share by Application, 2021
FIG 11 Global Hospital-Acquired Infection Diagnostics Market Share by Application, 2028
FIG 12 Global Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2028, USD Million
FIG 13 Global Hospital-Acquired Infection Diagnostics Market Share by Test Type, 2021
FIG 14 Global Hospital-Acquired Infection Diagnostics Market Share by Test Type, 2028
FIG 15 Global Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2028, USD Million
FIG 16 Global Hospital-Acquired Infection Diagnostics Market Share by End User, 2021
FIG 17 Global Hospital-Acquired Infection Diagnostics Market Share by End User, 2028
FIG 18 Global Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2028, USD Million
FIG 19 Global Hospital-Acquired Infection Diagnostics Market Share by Region, 2021
FIG 20 Global Hospital-Acquired Infection Diagnostics Market Share by Region, 2028
FIG 21 Global Hospital-Acquired Infection Diagnostics Market by Region, 2018 - 2028, USD Million
FIG 22 Recent Strategies and Developments: Becton, Dickinson and Company
FIG 23 Recent Strategies and Developments: Hologic, Inc.
FIG 24 Recent Strategies and Developments: Ecolab, Inc.
FIG 25 Recent Strategies and Developments: Pfizer, Inc.
FIG 26 Recent Strategies and Developments: Abbott Laboratories